Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure

Sponsor
Columbia University (Other)
Overall Status
Completed
CT.gov ID
NCT04408222
Collaborator
(none)
29
1
22.6
1.3

Study Details

Study Description

Brief Summary

The purpose of this study is to retrospectively review clinical data to determine whether awake proning improves oxygenation in spontaneously breathing patients with COVID-19 severe hypoxemic respiratory failure.

Condition or Disease Intervention/Treatment Phase
  • Other: Awake proning

Detailed Description

Critically ill patients with coronavirus disease 2019 (COVID-19) severely strained intensive care resources in New York in April 2020. The prone position improves oxygenation in intubated patients with acute respiratory distress syndrome. The investigators wanted to study whether the prone position is associated with improved oxygenation and decreased risk for intubation in spontaneously breathing patients with severe COVID-19 hypoxemic respiratory failure. Awake prone positioning was implemented based on the health care provider decision.

Study Design

Study Type:
Observational
Actual Enrollment :
29 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Awake Proning in Patients With COVID-19-Induced Acute Hypoxemic Respiratory Failure
Actual Study Start Date :
Apr 16, 2020
Actual Primary Completion Date :
Apr 16, 2021
Actual Study Completion Date :
Mar 6, 2022

Arms and Interventions

Arm Intervention/Treatment
Awake Proning

COVID-19 patients with hypoxemic respiratory failure with awake prone positioning, as tolerated, up to 24 hours daily.

Other: Awake proning
Prone positioning of awake, as tolerated, for up to 24 hours daily.

Outcome Measures

Primary Outcome Measures

  1. Change in SpO2 [Before proning and 1 hour after initiation of the prone position]

    SpO2 was measured by peripheral pulse oximetry.

Secondary Outcome Measures

  1. Mean Risk Difference in Intubation Rates [Duration of hospitalization or up to 1 month from admission]

    The mean risk difference in intubation rates for patients with SpO2 ≥95% vs. <95% 1 hour after initiation of the prone position was assessed.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Consecutive patients admitted to the Columbia University step-down unit from April 6,
  • Laboratory confirmed COVID-19 infection with severe hypoxemic respiratory failure defined as respiratory rate ≥30 breaths/min and oxyhemoglobin saturation (SpO2) ≤93% while receiving supplemental oxygen 6 L/min via nasal cannula and 15 L/min via non-rebreather facemask.
Exclusion Criteria:
  • Altered mental status with inability to turn in bed without assistance

  • Extreme respiratory distress requiring immediate intubation, or oxygen requirements less than specified in the inclusion criteria.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Columbia University Irving Medical Center New York New York United States 10032

Sponsors and Collaborators

  • Columbia University

Investigators

  • Principal Investigator: Sanja Jelic, MD, Columbia University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sanja Jelic, Associate Professor of Medicine, Columbia University
ClinicalTrials.gov Identifier:
NCT04408222
Other Study ID Numbers:
  • AAAT0134
First Posted:
May 29, 2020
Last Update Posted:
Mar 9, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sanja Jelic, Associate Professor of Medicine, Columbia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2022